Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 22 | 2015 | 218 | 2.170 |
Why?
|
| Alzheimer Disease | 16 | 2022 | 606 | 1.100 |
Why?
|
| Wills | 4 | 2013 | 5 | 0.990 |
Why?
|
| Geriatric Psychiatry | 14 | 2021 | 18 | 0.980 |
Why?
|
| Antipsychotic Agents | 8 | 2005 | 151 | 0.860 |
Why?
|
| Mental Competency | 4 | 2013 | 50 | 0.840 |
Why?
|
| Geriatric Assessment | 9 | 2009 | 192 | 0.780 |
Why?
|
| Expert Testimony | 4 | 2013 | 34 | 0.760 |
Why?
|
| Antidepressive Agents | 7 | 2004 | 113 | 0.750 |
Why?
|
| Psychotic Disorders | 5 | 2021 | 231 | 0.690 |
Why?
|
| Mental Disorders | 10 | 2004 | 463 | 0.670 |
Why?
|
| Sertraline | 4 | 2004 | 8 | 0.550 |
Why?
|
| Aged | 58 | 2015 | 20848 | 0.530 |
Why?
|
| Depressive Disorder | 7 | 2001 | 226 | 0.510 |
Why?
|
| Delirium | 2 | 2013 | 79 | 0.460 |
Why?
|
| Caregivers | 3 | 2007 | 185 | 0.430 |
Why?
|
| Psychiatric Status Rating Scales | 8 | 2004 | 504 | 0.430 |
Why?
|
| Behavioral Symptoms | 2 | 2004 | 15 | 0.410 |
Why?
|
| Terminally Ill | 1 | 2013 | 22 | 0.410 |
Why?
|
| Aged, 80 and over | 26 | 2015 | 7215 | 0.390 |
Why?
|
| Neuropsychological Tests | 11 | 2022 | 548 | 0.380 |
Why?
|
| Depressive Disorder, Major | 2 | 2007 | 174 | 0.350 |
Why?
|
| Primary Health Care | 3 | 2003 | 391 | 0.350 |
Why?
|
| Risperidone | 3 | 2005 | 24 | 0.320 |
Why?
|
| Cognition Disorders | 3 | 2015 | 244 | 0.290 |
Why?
|
| Nursing Homes | 5 | 2000 | 113 | 0.290 |
Why?
|
| Cognitive Dysfunction | 2 | 2022 | 192 | 0.290 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2004 | 49 | 0.260 |
Why?
|
| Telecommunications | 1 | 2007 | 8 | 0.260 |
Why?
|
| Patient Care Team | 3 | 2003 | 307 | 0.260 |
Why?
|
| Humans | 70 | 2022 | 95799 | 0.260 |
Why?
|
| Social Behavior Disorders | 2 | 1996 | 20 | 0.240 |
Why?
|
| Depression | 3 | 2003 | 560 | 0.230 |
Why?
|
| Serotonin Antagonists | 1 | 2004 | 35 | 0.220 |
Why?
|
| Internet | 1 | 2007 | 340 | 0.220 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 146 | 0.220 |
Why?
|
| Physician's Role | 2 | 2003 | 186 | 0.220 |
Why?
|
| Phenylcarbamates | 1 | 2004 | 6 | 0.220 |
Why?
|
| Carbamates | 1 | 2004 | 16 | 0.210 |
Why?
|
| Clinical Trials as Topic | 6 | 2004 | 1166 | 0.210 |
Why?
|
| Homes for the Aged | 4 | 2000 | 26 | 0.210 |
Why?
|
| Aging | 6 | 2006 | 766 | 0.210 |
Why?
|
| Case Management | 1 | 2003 | 29 | 0.200 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 102 | 0.200 |
Why?
|
| Congresses as Topic | 1 | 2003 | 125 | 0.190 |
Why?
|
| Psychotropic Drugs | 2 | 2003 | 82 | 0.170 |
Why?
|
| Psychomotor Agitation | 3 | 2001 | 31 | 0.170 |
Why?
|
| Patient Admission | 2 | 2005 | 122 | 0.160 |
Why?
|
| Telemedicine | 1 | 2003 | 229 | 0.160 |
Why?
|
| Frail Elderly | 3 | 2003 | 92 | 0.160 |
Why?
|
| Male | 31 | 2015 | 45685 | 0.160 |
Why?
|
| Treatment Outcome | 9 | 2007 | 9167 | 0.160 |
Why?
|
| Female | 34 | 2015 | 49869 | 0.160 |
Why?
|
| Nortriptyline | 1 | 1999 | 6 | 0.150 |
Why?
|
| Coercion | 2 | 2009 | 16 | 0.150 |
Why?
|
| Behavior | 3 | 1996 | 87 | 0.150 |
Why?
|
| Fluoxetine | 1 | 1999 | 42 | 0.140 |
Why?
|
| Benzodiazepines | 3 | 2005 | 71 | 0.140 |
Why?
|
| Managed Care Programs | 2 | 2003 | 43 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Health Services Needs and Demand | 2 | 1992 | 114 | 0.130 |
Why?
|
| United States | 14 | 2015 | 7764 | 0.130 |
Why?
|
| Malpractice | 1 | 1997 | 57 | 0.130 |
Why?
|
| Cognition | 5 | 2022 | 635 | 0.120 |
Why?
|
| Double-Blind Method | 6 | 2004 | 1791 | 0.120 |
Why?
|
| Health Care Reform | 1 | 1997 | 86 | 0.120 |
Why?
|
| Thiothixene | 1 | 1996 | 1 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 1996 | 13 | 0.120 |
Why?
|
| Physical Examination | 1 | 1997 | 153 | 0.120 |
Why?
|
| Quetiapine Fumarate | 2 | 2005 | 4 | 0.120 |
Why?
|
| Dibenzothiazepines | 2 | 2005 | 4 | 0.120 |
Why?
|
| Activities of Daily Living | 4 | 2001 | 216 | 0.110 |
Why?
|
| Suicide | 2 | 1995 | 162 | 0.110 |
Why?
|
| Middle Aged | 17 | 2015 | 28206 | 0.110 |
Why?
|
| Mass Screening | 2 | 2022 | 710 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2015 | 72 | 0.110 |
Why?
|
| Thiazoles | 2 | 2005 | 130 | 0.110 |
Why?
|
| Psychotherapy, Group | 2 | 1990 | 37 | 0.100 |
Why?
|
| Mental Status Schedule | 2 | 1993 | 27 | 0.100 |
Why?
|
| Home Care Services | 3 | 2003 | 77 | 0.100 |
Why?
|
| Ethics, Clinical | 1 | 2013 | 48 | 0.100 |
Why?
|
| Schizophrenia | 4 | 2001 | 532 | 0.100 |
Why?
|
| Piperazines | 2 | 2005 | 296 | 0.100 |
Why?
|
| Community Health Services | 2 | 2007 | 81 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2007 | 936 | 0.100 |
Why?
|
| Ethics, Medical | 1 | 1996 | 312 | 0.100 |
Why?
|
| Eligibility Determination | 1 | 1992 | 38 | 0.090 |
Why?
|
| Research Design | 1 | 1996 | 630 | 0.090 |
Why?
|
| Clozapine | 2 | 2004 | 9 | 0.090 |
Why?
|
| Terminal Care | 1 | 2013 | 146 | 0.090 |
Why?
|
| Age Factors | 6 | 2015 | 1957 | 0.090 |
Why?
|
| Sleep | 2 | 2006 | 459 | 0.090 |
Why?
|
| Circadian Rhythm | 3 | 2004 | 299 | 0.090 |
Why?
|
| Schizophrenic Psychology | 3 | 2000 | 141 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 1981 | 0.080 |
Why?
|
| Paranoid Disorders | 1 | 1990 | 6 | 0.080 |
Why?
|
| Medical Informatics | 1 | 1991 | 48 | 0.080 |
Why?
|
| House Calls | 1 | 1990 | 13 | 0.080 |
Why?
|
| Quality of Life | 4 | 2006 | 1816 | 0.080 |
Why?
|
| Publishing | 1 | 1991 | 94 | 0.080 |
Why?
|
| Mental Health | 2 | 2006 | 202 | 0.080 |
Why?
|
| Medicaid | 1 | 1992 | 260 | 0.070 |
Why?
|
| Forensic Psychiatry | 1 | 2009 | 7 | 0.070 |
Why?
|
| Memory | 2 | 2004 | 229 | 0.070 |
Why?
|
| Exercise | 2 | 2004 | 355 | 0.070 |
Why?
|
| Elder Abuse | 1 | 2008 | 1 | 0.070 |
Why?
|
| Living Wills | 1 | 2008 | 4 | 0.070 |
Why?
|
| Bronchogenic Cyst | 1 | 1988 | 5 | 0.070 |
Why?
|
| Medicare | 1 | 1992 | 458 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 1991 | 171 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1965 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2474 | 0.070 |
Why?
|
| Computer-Assisted Instruction | 1 | 1989 | 48 | 0.070 |
Why?
|
| Psychiatry | 2 | 2001 | 90 | 0.070 |
Why?
|
| Research | 3 | 1996 | 265 | 0.070 |
Why?
|
| Cost of Illness | 2 | 2007 | 161 | 0.070 |
Why?
|
| Stomach | 1 | 1988 | 115 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 169 | 0.070 |
Why?
|
| Social Work | 1 | 2007 | 22 | 0.070 |
Why?
|
| Risk Factors | 4 | 2018 | 5961 | 0.060 |
Why?
|
| Haloperidol | 1 | 2005 | 29 | 0.060 |
Why?
|
| Social Behavior | 3 | 2000 | 309 | 0.060 |
Why?
|
| Aripiprazole | 1 | 2004 | 6 | 0.060 |
Why?
|
| Anxiety Disorders | 2 | 1992 | 156 | 0.050 |
Why?
|
| Rivastigmine | 1 | 2004 | 4 | 0.050 |
Why?
|
| Quinolones | 1 | 2004 | 57 | 0.050 |
Why?
|
| Health Status | 1 | 2006 | 386 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2004 | 84 | 0.050 |
Why?
|
| Nootropic Agents | 1 | 2004 | 12 | 0.050 |
Why?
|
| Electroshock | 1 | 2003 | 17 | 0.050 |
Why?
|
| Indans | 1 | 2004 | 37 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 1996 | 21 | 0.050 |
Why?
|
| Capitation Fee | 1 | 2003 | 2 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2003 | 127 | 0.050 |
Why?
|
| Spouses | 1 | 2003 | 32 | 0.050 |
Why?
|
| Piperidines | 1 | 2004 | 171 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2004 | 198 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 3904 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 12 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 787 | 0.040 |
Why?
|
| Hospitalization | 2 | 2005 | 943 | 0.040 |
Why?
|
| Health Services Research | 1 | 1982 | 148 | 0.040 |
Why?
|
| Counseling | 1 | 2003 | 174 | 0.040 |
Why?
|
| Disease Management | 1 | 2003 | 360 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 2 | 2001 | 35 | 0.040 |
Why?
|
| Delusions | 1 | 2001 | 12 | 0.040 |
Why?
|
| Hallucinations | 1 | 2001 | 31 | 0.040 |
Why?
|
| Psychometrics | 3 | 2001 | 340 | 0.040 |
Why?
|
| Consultants | 1 | 1980 | 7 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2004 | 397 | 0.040 |
Why?
|
| Research Personnel | 1 | 2001 | 84 | 0.040 |
Why?
|
| Sleep Stages | 1 | 2000 | 47 | 0.040 |
Why?
|
| Nimodipine | 1 | 1999 | 12 | 0.040 |
Why?
|
| Mental Health Services | 1 | 1980 | 78 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 1997 | 2882 | 0.040 |
Why?
|
| Melatonin | 1 | 1999 | 48 | 0.040 |
Why?
|
| Adult | 7 | 2015 | 28578 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2000 | 1613 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 122 | 0.040 |
Why?
|
| Forecasting | 2 | 1991 | 317 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 370 | 0.040 |
Why?
|
| Syndrome | 1 | 2000 | 450 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2000 | 327 | 0.040 |
Why?
|
| Lorazepam | 1 | 1978 | 14 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2001 | 255 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 1999 | 162 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1978 | 23 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 267 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 587 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 3106 | 0.040 |
Why?
|
| Pirenzepine | 1 | 1997 | 8 | 0.030 |
Why?
|
| Psychotherapy | 3 | 1997 | 73 | 0.030 |
Why?
|
| Decision Making | 1 | 2003 | 694 | 0.030 |
Why?
|
| Hypertension | 1 | 2003 | 774 | 0.030 |
Why?
|
| Weight Loss | 1 | 1999 | 240 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1999 | 908 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2010 | 10273 | 0.030 |
Why?
|
| Thromboembolism | 1 | 1997 | 128 | 0.030 |
Why?
|
| Heart Rate | 1 | 1999 | 518 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 1997 | 231 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 1995 | 22 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 1230 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2010 | 4664 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2018 | 565 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 463 | 0.030 |
Why?
|
| Mental Recall | 2 | 2000 | 173 | 0.020 |
Why?
|
| Personality Disorders | 1 | 1995 | 145 | 0.020 |
Why?
|
| Curriculum | 1 | 1978 | 615 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 1995 | 213 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1993 | 90 | 0.020 |
Why?
|
| Health Services for the Aged | 2 | 1997 | 32 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 640 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 1992 | 26 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 1978 | 777 | 0.020 |
Why?
|
| Recurrence | 1 | 1995 | 1211 | 0.020 |
Why?
|
| Specialization | 1 | 1992 | 68 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1992 | 88 | 0.020 |
Why?
|
| Geriatrics | 1 | 1992 | 72 | 0.020 |
Why?
|
| Observer Variation | 1 | 1993 | 626 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 1992 | 203 | 0.020 |
Why?
|
| Length of Stay | 1 | 1995 | 833 | 0.020 |
Why?
|
| Comorbidity | 1 | 1995 | 1011 | 0.020 |
Why?
|
| Information Services | 1 | 1991 | 23 | 0.020 |
Why?
|
| Medicine | 1 | 1992 | 97 | 0.020 |
Why?
|
| Fraud | 1 | 2010 | 6 | 0.020 |
Why?
|
| Illinois | 2 | 2003 | 530 | 0.020 |
Why?
|
| Germany | 2 | 2001 | 80 | 0.020 |
Why?
|
| Long-Term Care | 1 | 1990 | 63 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1992 | 983 | 0.020 |
Why?
|
| Gastric Fistula | 1 | 1988 | 4 | 0.020 |
Why?
|
| International Cooperation | 1 | 2008 | 134 | 0.020 |
Why?
|
| Internship and Residency | 1 | 1978 | 1134 | 0.020 |
Why?
|
| Chicago | 1 | 1993 | 1505 | 0.020 |
Why?
|
| Diaphragm | 1 | 1988 | 75 | 0.020 |
Why?
|
| Family Practice | 2 | 1997 | 85 | 0.020 |
Why?
|
| Radiography | 1 | 1988 | 823 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1997 | 686 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 189 | 0.010 |
Why?
|
| Peer Review | 1 | 1986 | 24 | 0.010 |
Why?
|
| Health Behavior | 1 | 2006 | 191 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 1986 | 137 | 0.010 |
Why?
|
| Colonoscopy | 1 | 1986 | 304 | 0.010 |
Why?
|
| Space Perception | 1 | 2004 | 120 | 0.010 |
Why?
|
| Cost Control | 1 | 2003 | 45 | 0.010 |
Why?
|
| Patient Care Management | 1 | 2003 | 30 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2003 | 31 | 0.010 |
Why?
|
| Affect | 1 | 2004 | 397 | 0.010 |
Why?
|
| Placebos | 2 | 1980 | 213 | 0.010 |
Why?
|
| France | 1 | 2001 | 54 | 0.010 |
Why?
|
| Community Psychiatry | 1 | 1980 | 1 | 0.010 |
Why?
|
| Choline | 1 | 1980 | 27 | 0.010 |
Why?
|
| Attitude of Health Personnel | 2 | 1978 | 682 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 514 | 0.010 |
Why?
|
| Polysomnography | 1 | 2000 | 155 | 0.010 |
Why?
|
| Light | 1 | 1999 | 297 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 2859 | 0.010 |
Why?
|
| Central Nervous System Agents | 1 | 1997 | 15 | 0.010 |
Why?
|
| Policy Making | 1 | 1997 | 63 | 0.010 |
Why?
|
| Greece | 1 | 1997 | 20 | 0.010 |
Why?
|
| Russia | 1 | 1997 | 28 | 0.010 |
Why?
|
| Health Resources | 1 | 1997 | 82 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 245 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1997 | 120 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 1805 | 0.010 |
Why?
|
| Physician-Patient Relations | 2 | 1992 | 635 | 0.010 |
Why?
|
| Health Policy | 1 | 1997 | 208 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1997 | 246 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1997 | 386 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 1349 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1997 | 491 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 1978 | 468 | 0.010 |
Why?
|
| Sick Role | 1 | 1992 | 13 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1992 | 79 | 0.010 |
Why?
|
| Role | 1 | 1971 | 11 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 1971 | 26 | 0.010 |
Why?
|
| Europe | 1 | 1992 | 349 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1971 | 32 | 0.010 |
Why?
|
| Alcoholism | 1 | 1992 | 191 | 0.010 |
Why?
|
| Health Promotion | 1 | 1992 | 176 | 0.010 |
Why?
|
| Time Factors | 1 | 1978 | 5561 | 0.000 |
Why?
|
| Sexual Behavior | 1 | 1992 | 334 | 0.000 |
Why?
|
| Sex Factors | 1 | 1992 | 1127 | 0.000 |
Why?
|
| Education, Medical | 1 | 1992 | 252 | 0.000 |
Why?
|
| Motivation | 1 | 1971 | 310 | 0.000 |
Why?
|
| Incidence | 1 | 1992 | 1714 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 1878 | 0.000 |
Why?
|